Dr. John Cush RheumNow
7 years 9 months ago
Obesity makes everything worse, including SLE! Study of 148 SLE pts; the 32% who were obese had worse disease activity, depression, pain and fatigue. https://t.co/PQOQrBca2a
An article in the New England Journal of Medicine reports that the rates of suicide and drug overdoses has doubled in the last 17 years, and that opioids are largely to blame.
Using data from the Centers for Disease Control and Prevention databases, researchers show that the sheer number of deaths from suicides and unintentional overdoses together rose from 41,364 in the year 2000 to 110,749 in 2017.
Reuters reports that Bristol-Myers Squibb (BMS) has announced its intention to buy Celgene Corp for nearly $74 billion in a cash-and-stock deal.
Celgene shareholders will receive one BMS share and $50 in cash per share (or $102.43 per share), and a premium of 53.7 percent to Celgene’s Wednesday close.
Dr. John Cush RheumNow
7 years 9 months ago
Rheumatology Year in Review - New Drugs, irAEs, Enbrel in court, Opioids, new JAKs, Hot PsA Trial, new Lupus drugs, Medical Marijuana, Expen$ive Rheum drugs, Senolytics. https://t.co/9VpM4yRGfY
Dr. John Cush RheumNow
7 years 9 months ago
RheumNow Weekly Podcast is up - watch here: https://t.co/vAtEYSPIhG or listen on iTunes or here https://t.co/D3n7so7mN9
Dr. John Cush RheumNow
7 years 9 months ago
Potential Blockbuster Takeover - BMS proposal to takeover Celgene for $74 Billion! Bristol-Myers' acquisition of Celgene would rank among the industry's largest ever. https://t.co/hWuygShcNq
NatRevRheumatol NatRevRheumatol
7 years 9 months ago
Learn about the pathophysiology, assessment & treatment of #psoriatic #dactylitis in our new #Perspectives article
Now online at https://t.co/ewqx3xdXTz
#PsoriaticArthritis #Arthritis #Enthesitis https://t.co/2bkHgKNGPQ
Secretary Alex Azar SecAzar
7 years 9 months ago
Happy birthday to the US Public Health Service Commissioned Corps. I’m proud of my colleagues who continue the Commissioned Corps’ 130-year legacy as the frontline defender of public health, providing critical health expertise and rapid response to public health emergencies.
Dr. John Cush RheumNow
7 years 9 months ago
2018 Rheumatology Year In Review | RheumNow - Rheumatology News & Information https://t.co/zo1AaWZ0MR
Dr. John Cush RheumNow
7 years 9 months ago
FDA warns fluoroquinolone use may increase risk ofruptures or tears in the aorta. Thus Fluoroquinolones should not be used w/ aortic aneurysms, peripheral vascular Dz, HTN, Marfans/Ehlers-Danlos, or the elderly, unless there are no other options available https://t.co/aTEE0keIS8
Dr. John Cush RheumNow
7 years 9 months ago
Finnish followup study of 68,800 hip fracture pts w hip surgery finds 4.6% w/ complications - esp with heavy alcoholism (HR 1.38); Parkinson’s (1.22); osteoarthritis (2.02); rheumatic Dz (1.44); those w/ depression/psychosis, operative delay, prior THR https://t.co/StahnHXRuZ
Dr. Jack Cush reviews the news and journals for the beginning of 2019. All from RheumNow.com.
Best wishes for a charmed 2019! My advice: 1. Just show up. 2. If you can, then you must do. 3. Live each day as if it twas your 1st day/last day/make or break day. 4. Teach.
This annual appraisal of hallmark moments, news and research articles from 2018 are gleaned from that published in RheumNow during the last year and filtered by other news sources and literature review. The top 10 list herein is rooted in what rheumatologists should know and what will likely change their standards and practice in the future, if not 2019.
